Table 2. Antimicrobial drug susceptibility of clinical bacterial strains from 5 patients who tested positive for Clostridium butyricum in a single-institute, retrospective study, Osaka University Hospital, Japan, and 3 medicinal strains from different lot numbers of C. butyricum MIYAIRI 588 strain.
| Category |
Patient strains |
|
Medicinal strains of CBM 588 |
||||||
| Patient no. | 1 | 2 | 3 | 4 | 5 | ||||
| Strain no. |
114–4 |
129–32 |
180–11 |
181–16 |
216–41 |
|
No. 1 |
No. 2 |
No. 3 |
| Antimicrobial drug | |||||||||
| Penicillin | 0.25 | 0.25 | 0.5 | 0.5 | 0.25 | 0.25 | 0.25 | 0.25 | |
| Ampicillin | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.12 | 0.25 | 0.25 | |
| Cefotaxime | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | |
| Ceftriaxone | 8 | 8 | 16 | 8 | 16 | 8 | 16 | 8 | |
| Cefmetazole | ≤4 | ≤4 | 8 | ≤4 | ≤4 | ≤4 | ≤4 | ≤4 | |
| Imipenem | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | |
| Meropenem | ≤0.12 | ≤0.12 | 0.5 | ≤0.12 | ≤0.12 | ≤0.12 | ≤0.12 | ≤0.12 | |
| Sulbactam/ampicillin | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | |
| Clavulanic acid/amoxicillin | 0.25 | 0.25 | 0.5 | 0.25 | 0.25 | 0.12 | 0.25 | 0.12 | |
| Tazobactam/piperacillin | ≤8 | ≤8 | ≤8 | ≤8 | ≤8 | ≤8 | ≤8 | ≤8 | |
| Clindamycin | 0.5 | 0.25 | 0.5 | 0.5 | 0.25 | 0.25 | 0.5 | 0.25 | |
| Moxifloxacin | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | |
| Metronidazole | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | ≤2 | |